Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten L Simoons

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|January 29, 2002
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsEric Boersma, Robert A Harrington, David J Moliterno, et al.
European Heart Journal|December 25, 2004
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trialsMarino Labinaz, Jasmine Mathias, Karen Pieper, et al.
Journal of the American Heart Association|March 30, 2016
Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk ModelRohit M Oemrawsingh, K Martijn Akkerhuis, Laura C Van Vark, et al.
Circulation|July 18, 2002
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomesSana M Al-Khatib, Christopher B Granger, Yao Huang, et al.
European Heart Journal|February 6, 2013
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacyFreek W A Verheugt, Peter Clemmensen, Roxana Mehran, et al.
The American Journal of Cardiology|June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromesKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
American Heart Journal|December 22, 2005
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trialsJohn M Galla, Kenneth W Mahaffey, Shelly K Sapp, et al.
The American Journal of Cardiology|November 26, 2009
Prognostic significance of QRS duration in patients with suspected coronary artery disease referred for noninvasive evaluation of myocardial ischemiaArend F L Schinkel, Abdou Elhendy, Ron T van Domburg, et al.
The New England Journal of Medicine|September 3, 2013
Dabigatran versus warfarin in patients with mechanical heart valvesJohn W Eikelboom, Stuart J Connolly, Martina Brueckmann, et al.
International Journal of Cardiology|February 21, 2012
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 yearsMark Y Chan, Jie-Lena Sun, L Kristin Newby, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|January 29, 2002
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trialsEric Boersma, Robert A Harrington, David J Moliterno, et al.
European Heart Journal|December 25, 2004
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trialsMarino Labinaz, Jasmine Mathias, Karen Pieper, et al.
Journal of the American Heart Association|March 30, 2016
Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk ModelRohit M Oemrawsingh, K Martijn Akkerhuis, Laura C Van Vark, et al.
Circulation|July 18, 2002
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomesSana M Al-Khatib, Christopher B Granger, Yao Huang, et al.
European Heart Journal|February 6, 2013
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacyFreek W A Verheugt, Peter Clemmensen, Roxana Mehran, et al.
The American Journal of Cardiology|June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromesKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
American Heart Journal|December 22, 2005
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trialsJohn M Galla, Kenneth W Mahaffey, Shelly K Sapp, et al.
The American Journal of Cardiology|November 26, 2009
Prognostic significance of QRS duration in patients with suspected coronary artery disease referred for noninvasive evaluation of myocardial ischemiaArend F L Schinkel, Abdou Elhendy, Ron T van Domburg, et al.
The New England Journal of Medicine|September 3, 2013
Dabigatran versus warfarin in patients with mechanical heart valvesJohn W Eikelboom, Stuart J Connolly, Martina Brueckmann, et al.
International Journal of Cardiology|February 21, 2012
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 yearsMark Y Chan, Jie-Lena Sun, L Kristin Newby, et al.
Pageof 19